Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

TPST

Tempest Therapeutics Inc

Jun 11 • 04:00PM ET

1.25

-0.02 -1.57 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: ALLR BCTX CLRB JSPR LGVN MRKR NXTC PLUR PTN VTGN

| Held by: VXF VTI

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-6.21	Insider Own	43.33%	Shs Outstand	14.34M	Perf Week	-3.85%
Market Cap	18.50M	Forward P/E	-	EPS next Y	-1.21	Insider Trans	3.74%	Shs Float	8.39M	Perf Month	-34.90%
Enterprise Value	24.55M	PEG	-	EPS next Q	-0.30	Inst Own	3.27%	Short Float	4.07%	Perf Quarter	-45.41%
Income	-43.10M	P/S	-	EPS this Y	78.83%	Inst Trans	-1.15%	Short Ratio	1.67	Perf Half Y	-60.94%
Sales	0.00M	P/B	21.81	EPS next Y	9.70%	ROA	-200.87%	Short Interest	0.34M	Perf YTD	-56.45%
Book/sh	0.06	P/C	10.28	EPS next 5Y	48.00%	ROE	-721.00%	52W High	12.23 -89.78%	Perf Year	-83.27%
Cash/sh	0.12	P/FCF	-	EPS past 3/5Y	46.00% 76.03%	ROIC	-579.51%	52W Low	1.23 1.63%	Perf 3Y	-91.92%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	3.92% 6.57%	Perf 5Y	-99.53%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	65.65%	Oper. Margin	-	ATR (14)	0.11	Perf 10Y	-99.99%
Dividend Ex-Date	-	Quick Ratio	0.74	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	29.21	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	0.74	EPS Q/Q	19.80%	SMA20	-20.71%	Beta	-1.62	Target Price	11.00
Payout	-	Debt/Eq	9.57	Sales Q/Q	-	SMA50	-29.03%	Rel Volume	0.20	Prev Close	1.27
Employees	4	LT Debt/Eq	8.07	Earnings	May 14 AMC	SMA200	-73.43%	Avg Volume	204.56K	Price	1.25
IPO	Nov 12, 2012	Option/Short	No / Yes	EPS/Sales Surpr.	-803.57% -	Trades		Volume	41,344	Change	-1.57%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)